Skip to main content
Top
Published in: Reactions Weekly 1/2023

01-01-2023 | Helicobacter Pylori | Case report

Pembrolizumab

Gastric ulcer: case report

Published in: Reactions Weekly | Issue 1/2023

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Terasaki K, et al. Gastrointestinal: Pembrolizumab-induced gastric ulcer occurring as an immune-related adverse event. [Review]. Journal of Gastroenterology and Hepatology 37: 1472, No. 8, Aug 2022. Available from: URL: http://doi.org/10.1111/jgh.15788 Terasaki K, et al. Gastrointestinal: Pembrolizumab-induced gastric ulcer occurring as an immune-related adverse event. [Review]. Journal of Gastroenterology and Hepatology 37: 1472, No. 8, Aug 2022. Available from: URL: http://​doi.​org/​10.​1111/​jgh.​15788
Metadata
Title
Pembrolizumab
Gastric ulcer: case report
Publication date
01-01-2023
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-31199-z

Other articles of this Issue 1/2023

Reactions Weekly 1/2023 Go to the issue

Case report

Dorzolamide

Case report

Digoxin

Case report

Methotrexate

Case report

Clonazepam